rs568626378
Variant summary
Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP4_StrongBP6
The NM_005751.5(AKAP9):c.5284A>G(p.Lys1762Glu) variant causes a missense change. The variant allele was found at a frequency of 0.0000632 in 1,613,874 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. K1762R) has been classified as Uncertain significance.
Frequency
Consequence
NM_005751.5 missense
Scores
Clinical Significance
Conservation
Publications
- male infertility with azoospermia or oligozoospermia due to single gene mutationInheritance: AR Classification: MODERATE Submitted by: King Faisal Specialist Hospital and Research Center
- long QT syndrome 11Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
- long QT syndromeInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -5 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| AKAP9 | ENST00000356239.8 | c.5284A>G | p.Lys1762Glu | missense_variant | Exon 21 of 50 | 1 | NM_005751.5 | ENSP00000348573.3 |
Frequencies
GnomAD3 genomes AF: 0.0000790 AC: 12AN: 151948Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.000299 AC: 75AN: 251188 AF XY: 0.000236 show subpopulations
GnomAD4 exome AF: 0.0000616 AC: 90AN: 1461808Hom.: 0 Cov.: 32 AF XY: 0.0000509 AC XY: 37AN XY: 727212 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000789 AC: 12AN: 152066Hom.: 0 Cov.: 32 AF XY: 0.0000807 AC XY: 6AN XY: 74320 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not specified Uncertain:1Benign:1
- -
Variant summary: AKAP9 c.5284A>G (p.Lys1762Glu) results in a conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.0003 in 251188 control chromosomes, predominantly at a frequency of 0.0021 within the Latino subpopulation in the gnomAD database. The observed variant frequency within Latino control individuals in the gnomAD database is approximately 630 fold of the estimated maximal expected allele frequency for a pathogenic variant in AKAP9 causing Long QT Syndrome phenotype (3.3e-06), strongly suggesting that the variant is a benign polymorphism found primarily in populations of Latino origin. c.5284A>G has been reported in the literature (Marquez_2015, Zhang_2015). These reports however, do not provide unequivocal conclusions about association of the variant with Long QT Syndrome. Co-occurrence with another pathogenic variant has been reported (SCN5A c.4931G>A, p.Arg1644His), providing supporting evidence for a benign role (Marquez_2015). To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Two ClinVar submitters (evaluation after 2014) cite the variant as likely benign or uncertain significance. Based on the evidence outlined above, the variant was classified as likely benign. -
AKAP9-related disorder Benign:1
This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Long QT syndrome Benign:1
- -
Cardiovascular phenotype Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at